The global apheresis equipment market was valued at USD 3.0 billion in 2022 and is projected to reach approximately USD 8.51 billion by 2032, growing at a strong CAGR of 11% over the forecast period from 2023 to 2032. The market’s growth is driven by the expanding clinical applications of apheresis both as a primary therapy and as an adjunct in treating complex conditions like autoimmune diseases, hemolytic uremic syndrome, and fulminant hepatic failure. Additionally, technological advancements in device automation and safety features are further propelling adoption.
Market Overview
Apheresis is a medical procedure that removes whole blood from a donor or patient, separates specific blood components (such as plasma, platelets, or leukocytes), and then returns the remaining blood components back to circulation. This targeted separation plays a crucial role in therapeutic and donor applications.
Historical Growth and Evolution: Historically limited to donor plasma collection, apheresis has evolved significantly due to improvements in centrifugation and filtration technologies. Over recent decades, it has become an integral part of therapeutic protocols for autoimmune diseases, oncology, and critical care, driven by increasing awareness among clinicians and wider clinical research backing.
Major Genres / Application Segments:
Therapeutic apheresis (treating diseases like thrombotic thrombocytopenic purpura and sepsis)
Donor apheresis (collection of plasma, platelets, and leukocytes)
Research applications and cell-based therapies
Grab The Sample Report ➣ https://www.thebrainyinsights.com/enquiry/sample-request/13690
Market Dynamics
Drivers:
Expanding use of apheresis in managing autoimmune and hematological disorders.
Increasing demand for blood components in hospitals and blood banks.
Technological advancements leading to safer, faster, and automated procedures.
Restraints:
High equipment costs limiting adoption in smaller clinics and low-income regions.
Risks of complications such as bleeding or infection during the procedure.
Opportunities:
Integration of apheresis with advanced cell therapies and regenerative medicine.
Rising demand in emerging economies due to improving healthcare infrastructure.
Research-driven innovations leading to portable and user-friendly devices.
Market Segmentation
By Type: Plasma apheresis devices, platelet apheresis devices, leukocyte apheresis devices, photopheresis systems, others.
By Genre/Application: Therapeutic, donor apheresis, research and cell therapy.
By Distribution: Hospitals, blood banks, ambulatory care centers, research institutions.
By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
Competitive Landscape
Key industry players focus on innovation, partnerships, and global reach to remain competitive:
Fresenius Kabi AG: Leading with advanced therapeutic apheresis systems and a broad global footprint.
Haemonetics Corporation: Specializes in donor apheresis and cutting-edge automation technologies.
Terumo BCT Inc.: Notable for cell therapy applications and versatile product range.
Asahi Kasei Medical Co., Ltd.: Offers specialized devices, especially in Asia-Pacific markets.
B. Braun Melsungen AG: Focuses on quality and safety in therapeutic apheresis equipment.
These companies invest heavily in R&D and collaborate with hospitals and research centers to advance apheresis technology.
Region-wise Trends
North America: Largest market share due to high healthcare spending, established blood bank infrastructure, and early technology adoption.
Europe: Strong demand supported by rising prevalence of autoimmune and hematological disorders.
Asia-Pacific: Expected to witness the fastest growth driven by expanding healthcare infrastructure and growing clinical awareness in countries like China, India, and Japan.
Latin America & Middle East & Africa: Gradual adoption, driven by increasing investment in healthcare and partnerships with global manufacturers.